Skip to main content
SpringerLink
Log in

Insulin sensitivity and premenstrual syndrome

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Maintaining normal blood glucose levels is a constant challenge for women with diabetes. Anecdotal reports reveal that many women question if menstrual cycle phases may affect their blood glucose levels. However, results from studies investigating the effect of the menstrual cycle on insulin sensitivity in diabetic women have been conflicting. One variable that may account for the conflicting results is the presence or absence of premenstrual syndrome (PMS), which may exacerbate menstrual cycle-related effects on insulin sensitivity. Treatment of PMS with serotonin reuptake inhibitors may alleviate the symptoms of PMS, as well as improve insulin sensitivity and help regulate blood glucose levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lunt H, Brown LJ: Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle. Diabet Med 1996, 13:525–530.

    Article  PubMed  CAS  Google Scholar 

  2. Cawood EH, Bancroft J, Steel JM: Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med 1993, 10:444–448.

    PubMed  CAS  Google Scholar 

  3. Cramer HI: The influence of menstruation on carbohydrate tolerance in diabetes mellitus. CMAJ 1942, 47:51–55.

    CAS  Google Scholar 

  4. Pulido JME, Salazar MA: Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 1999, 30:19–22. Study showing differences in insulin sensitivity between menstrual cycle phases in nondiabetic women.

    Article  CAS  Google Scholar 

  5. Valdes CT, Elkind-Hirsch KE: Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab 1991, 72:642–646.

    PubMed  CAS  Google Scholar 

  6. Ezenwaka EC, Akanji AO, Adejuwon CA, et al.: Insulin responses following glucose administration in menstruating women. Int J Gynecol Obstet 1993, 42:155–159.

    Article  CAS  Google Scholar 

  7. Spellacy WN, Ellingson AB, Keith G, et al.: Plasma glucose and insulin levels during the menstrual cycles of normal women and premenstrual syndrome patients. J Reprod Med 1990, 35:508–511.

    PubMed  CAS  Google Scholar 

  8. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.

    Google Scholar 

  9. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987, 79:790–800.

    Article  PubMed  CAS  Google Scholar 

  10. Widom B, Diamond MP, Simonson DC: Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care 1992, 15:213–220.

    Article  PubMed  CAS  Google Scholar 

  11. Scott AR, Macdonald IA, Bowman CA, Jeffcoate WJ: Effect of phase of menstrual cycle on insulin sensitivity, peripheral blood flow and cardiovascular responses to hyperinsulinaemia in young women with type 1 diabetes. Diabet Med 1990, 7:57–62.

    PubMed  CAS  Google Scholar 

  12. Moberg E, Kollind M, Lins PE, Adamson U: Day-to-day variation of insulin sensitivity in patients with type 1 diabetes: role of gender and menstrual cycle. Diabet Med 1995, 12:224–228.

    PubMed  CAS  Google Scholar 

  13. Strotmeyer ES, Steenkiste AR, Foley TP, et al.: Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003, 26:1016–1021.

    Article  PubMed  Google Scholar 

  14. Solomon CG, Hu FB, Dunaif A, et al.: Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001, 286:2421–2426.

    Article  PubMed  CAS  Google Scholar 

  15. Beckles GLA, Thompson-Reid PE, eds: Diabetes and Women's Health Across the Life Stages: A Public Health Perspective. Atlanta: U.S. Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation; 2001.

    Google Scholar 

  16. Rubin RR, Peyrot M: Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes Metab Res Rev2002, 18:173–175.

    Article  PubMed  Google Scholar 

  17. Chu PC, Lin MT, Shian LR, Leu SY: Alterations in physiologic functions and in brain monoamine content in streptozocindiabetic rats. Diabetes 1986, 35:481–485.

    Article  PubMed  CAS  Google Scholar 

  18. Steiner M, Pearlstein T: Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry 2000, 61(suppl 12):17–21.

    PubMed  Google Scholar 

  19. American College of Obstetricians and Gynecologists: Premenstrual Syndrome. ACOG Practice Bulletin No. 15. Washington, DC: American College of Obstetricians and Gynecologists; 2000.

    Google Scholar 

  20. Ugarizza DN, Klingner S, O'Brien S: Premenstrual syndrome: diagnosis and intervention. Nurse Pract 1998, 23:44–58.

    Google Scholar 

  21. Magyar DM, Boyers SP, Marshall JR, Abraham GE: Regular menstrual cycles and premenstrual molimina as indicators of ovulation. Obstet Gynecol 1979, 53:411–414.

    PubMed  CAS  Google Scholar 

  22. Budeiri DJ, Po ALW, Dornan JC: Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol 1994, 101:689–695.

    PubMed  CAS  Google Scholar 

  23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4 (text revision). Washington, DC: American Psychiatric Association; 2000.

    Book  Google Scholar 

  24. Ling FW: Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices. J Clin Psychiatry 2000, 61:9–16.

    Article  PubMed  Google Scholar 

  25. Dennerstein L, Brown JB, Gotts G, et al.: Menstrual cycle hormonal profiles of women with and without premenstrual syndrome. J Psychosom Obstet Gynaecol 1993, 14:259–268.

    PubMed  CAS  Google Scholar 

  26. Rubinow DR, Hoban MC, Grover GN, et al.: Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 1988, 158:5–11.

    PubMed  CAS  Google Scholar 

  27. Schmidt PJ, Nieman LK, Danaceau MA, et al.: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998, 338:209–216.

    Article  PubMed  CAS  Google Scholar 

  28. Steiner M, Steinberg S, Stewart D, et al.: Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995, 332:1529–1534.

    Article  PubMed  CAS  Google Scholar 

  29. Rapkin A: A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 2003, 28:39–53. Good overview of diagnosis and treatment for PMS and PMDD.

    Article  PubMed  Google Scholar 

  30. Wonsiewicz MJ, Morriss JM, eds: Goodman and Gilman's The Pharmacological Basis of Therapeutics, edn 10. New York: McGraw-Hill; 2001.

    Google Scholar 

  31. Halbreich U, Tworek H: Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 1993, 23:1–27.

    Article  PubMed  CAS  Google Scholar 

  32. Jermain DM, Preece CK, Sykes RL, et al.: Luteal phase sertraline treatment for premenstrual dysphoric disorder. Arch Fam Med 1999, 8:328–332.

    Article  PubMed  CAS  Google Scholar 

  33. Reith MAE, ed: Neurotransmitter Transporters: Structure, Function, and Regulation. Totowa, NJ: Humana Press; 1997.

    Google Scholar 

  34. Biegon A, Bercovitz H, Samuel D: Serotonin receptor concentration during the estrous cycle of the rat. Brain Res 1980, 187:221–225.

    Article  PubMed  CAS  Google Scholar 

  35. Guidotti A, Costa E: Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3a, 5a-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998, 44:865–873.

    Article  PubMed  CAS  Google Scholar 

  36. Girdler SS, Straneva PA, Light KC, et al.: Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001, 49:788–797.

    Article  PubMed  CAS  Google Scholar 

  37. Purdy RH, Moore PH, Morrow AL, Paul SM: Neurosteroids and GABA-A receptor function. In GABAergic Synaptic Transmission. Edited by Biggio G, et al.New York: Raven Press; 1992:87–102.

    Google Scholar 

  38. Smith SS, Gong QH, Hsu FC, et al.: GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998, 392:926–930.

    Article  PubMed  CAS  Google Scholar 

  39. Hajduch E, Rencurel F, Balendran A, et al.: Serotonin (5-hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle. J Biol Chem 1999, 274:13563–13568. Study performed in rats that demonstrated increased glucose uptake in skeletal muscle caused by 5-hydroxytryptamine.

    Article  PubMed  CAS  Google Scholar 

  40. Endo Y: Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycemia induced by 5-hydroxytryptophan. Br J Pharmacol 1985, 85:591–598.

    PubMed  CAS  Google Scholar 

  41. Chaouloff F, Gunn SH, Young JB: Central 5-hydroxytryptamine-2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat. J Pharmacol Exp Ther 1992, 260:1008–1016.

    PubMed  CAS  Google Scholar 

  42. Potter van Loon BJ, Radder JK, Frolich M, et al.: Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes 1992, 16:79–85.

    Google Scholar 

  43. O'Kane M, Wiles PG, Wales JK: Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med 1994, 11:105–110.

    PubMed  Google Scholar 

  44. Pestell RG, Crock PA, Ward GM, et al.: Fenfluramine increases insulin action in patients with NIDDM. Diabetes Care 1989, 12:252–258.

    Article  PubMed  CAS  Google Scholar 

  45. Scheen AJ, Paolisso G, Salvatore T, Lefebvre PJ: Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine. Diabetes Care 1991, 14:325–332.

    Article  PubMed  CAS  Google Scholar 

  46. Proietto J, Thorburn AW, Fabris S, Harrison LC: Effects of dexfenfluramine on glucose turnover in non-insulindependent diabetes mellitus. Diabetes Res Clin Pract 1994, 23:127–134.

    Article  PubMed  CAS  Google Scholar 

  47. Takhar J, Williamson P: Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient. Can J Clin Pharmacol 1999, 6:12–14. Case study of acute hypoglycemia when sertraline and glyburide are used together.

    PubMed  CAS  Google Scholar 

  48. Dalvit-McPhillips SP: The effect of the human menstrual cycle on nutrient intake. Physiol Behav 1983, 31:209–212.

    Article  PubMed  CAS  Google Scholar 

  49. Wurtman JJ, Brzezinski A, Wurtman RJ, Laferrere B: Effect of nutrient intake on premenstrual depression. Am J Obstet Gynecol 1989, 161:1228–1234.

    PubMed  CAS  Google Scholar 

  50. Sayegh R, Schiff I, Wurtman J, et al.: The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995, 86:520–528.

    PubMed  CAS  Google Scholar 

  51. Teff KL, Young SN, Blundell JE: The effect of protein or carbohydrate breakfasts on subsequent amino acid levels, satiety and nutrient selection in normal males. Pharmacol Biochem Behav 1989, 4:829–837.

    Article  Google Scholar 

  52. Wyatt K, Dimmock P, O'Brien PM: Premenstrual syndrome. Clin Evid 2000, 4:1121–1133.

    Google Scholar 

  53. Shoupe D: Effects of desogestrel on carbohydrate metabolism. Am J Obstet Gynecol1993, 168(3 Pt 2):1041–1047.

    PubMed  CAS  Google Scholar 

  54. Gaspard U, Scheen A, Endrikat J, et al.: A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception 2003, 67:423–429.

    Article  PubMed  CAS  Google Scholar 

  55. Baron AD, Laakso M, Brechtel G, Edelman SV: Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 1991, 73:637–643.

    Article  PubMed  CAS  Google Scholar 

  56. DeSouza MC, Walker AF, Robinson PA, Bolland K: A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 2000, 9:131–139.

    Article  PubMed  Google Scholar 

  57. Thys-Jacobs S, Starkey P, Bernstein D, Tian J: Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998, 179:444–452.

    Article  PubMed  CAS  Google Scholar 

  58. Thys-Jacobs S, Ceccarelli S, Bierman A, et al.: Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989, 4:183–189.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Monell Chemical Senses Center, 3500 Market Street, 19104, Philadelphia, PA, USA

    Karen L. Teff PhD

Authors
  1. Kimberly K. Trout CNM, MSN
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen L. Teff PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trout, K.K., Teff, K.L. Insulin sensitivity and premenstrual syndrome. Curr Diab Rep 4, 273–280 (2004). https://doi.org/10.1007/s11892-004-0079-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-004-0079-4

Keywords

Search

Navigation